LMB vs MRNA · P/E 30, rev $312.3M vs rev $145.0M
Limbach Holdings Inc (LMB) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Limbach Holdings Inc (LMB) is a building products & equipment company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ.
Latest reported LMB revenue for 2026-06-30 was $312.3M. Net income was $9.1M. LMB currently screens at market cap $976.2M and trailing P/E 29.9.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
LMB currently screens at market cap $976.2M and trailing P/E 29.9. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the LMB and MRNA stock pages for the full models.
Not investment advice.